APA (7th ed.) Citation

J, L., RO, F., X, L., P, D., T, K., & S, R. (2026). Clinical Outcomes in Adult Patients Receiving Definitive Cefazolin Therapy for Community-Acquired Enterobacterales Bacteremias across Minimum Inhibitory Concentration Breakpoints. The Canadian journal of hospital pharmacy, 79(1), e3823. https://doi.org/10.4212/cjhp.3823

Chicago Style (17th ed.) Citation

J, Lam, Forrest RO, Li X, Das P, Kan T, and Raybardhan S. "Clinical Outcomes in Adult Patients Receiving Definitive Cefazolin Therapy for Community-Acquired Enterobacterales Bacteremias Across Minimum Inhibitory Concentration Breakpoints." The Canadian Journal of Hospital Pharmacy 79, no. 1 (2026): e3823. https://doi.org/10.4212/cjhp.3823.

MLA (9th ed.) Citation

J, Lam, et al. "Clinical Outcomes in Adult Patients Receiving Definitive Cefazolin Therapy for Community-Acquired Enterobacterales Bacteremias Across Minimum Inhibitory Concentration Breakpoints." The Canadian Journal of Hospital Pharmacy, vol. 79, no. 1, 2026, p. e3823, https://doi.org/10.4212/cjhp.3823.